Admire Dube

2.2k total citations
62 papers, 1.5k citations indexed

About

Admire Dube is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Admire Dube has authored 62 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Pharmaceutical Science and 13 papers in Biomaterials. Recurrent topics in Admire Dube's work include Advanced Drug Delivery Systems (13 papers), Nanoparticle-Based Drug Delivery (11 papers) and Pharmaceutical Economics and Policy (7 papers). Admire Dube is often cited by papers focused on Advanced Drug Delivery Systems (13 papers), Nanoparticle-Based Drug Delivery (11 papers) and Pharmaceutical Economics and Policy (7 papers). Admire Dube collaborates with scholars based in South Africa, United States and Zimbabwe. Admire Dube's co-authors include Ian Larson, Joseph A. Nicolazzo, Mervin Meyer, Ken Ng, Kim Ward, Sarah D’Souza, Rose Hayeshi, Hulda Swai, Charles C. Maponga and Nicole Remaliah Samantha Sibuyi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Food Chemistry.

In The Last Decade

Admire Dube

60 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Admire Dube South Africa 20 335 288 270 230 193 62 1.5k
Zhixiang Yuan China 28 357 1.1× 869 3.0× 112 0.4× 162 0.7× 241 1.2× 85 2.2k
Kamalinder K. Singh India 28 322 1.0× 582 2.0× 169 0.6× 951 4.1× 171 0.9× 90 2.5k
Lay‐Hong Chuah Malaysia 21 363 1.1× 821 2.9× 73 0.3× 221 1.0× 202 1.0× 50 2.2k
Mohammadreza Abbaspour Iran 26 365 1.1× 331 1.1× 102 0.4× 459 2.0× 203 1.1× 99 1.9k
Muchtaridi Muchtaridi Indonesia 26 645 1.9× 733 2.5× 54 0.2× 413 1.8× 374 1.9× 206 2.8k
Dorina Coricovac Romania 25 196 0.6× 743 2.6× 51 0.2× 91 0.4× 230 1.2× 72 2.0k
Srinivasan Sivasubramanian India 19 401 1.2× 397 1.4× 53 0.2× 65 0.3× 266 1.4× 32 1.2k
Sophia Hatziantoniou Greece 29 340 1.0× 1.0k 3.5× 43 0.2× 256 1.1× 177 0.9× 91 2.4k
Lingli Chen China 30 898 2.7× 1.2k 4.2× 81 0.3× 282 1.2× 519 2.7× 89 2.8k
Thiagarajan Madheswaran Malaysia 27 252 0.8× 586 2.0× 32 0.1× 316 1.4× 244 1.3× 55 1.9k

Countries citing papers authored by Admire Dube

Since Specialization
Citations

This map shows the geographic impact of Admire Dube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Admire Dube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Admire Dube more than expected).

Fields of papers citing papers by Admire Dube

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Admire Dube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Admire Dube. The network helps show where Admire Dube may publish in the future.

Co-authorship network of co-authors of Admire Dube

This figure shows the co-authorship network connecting the top 25 collaborators of Admire Dube. A scholar is included among the top collaborators of Admire Dube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Admire Dube. Admire Dube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khoza, Star, et al.. (2025). Vitamin D3 loaded polycaprolactone nanoparticles enhance the expression of the antimicrobial peptide cathelicidin in macrophages. Artificial Cells Nanomedicine and Biotechnology. 53(1). 207–219. 1 indexed citations
2.
Ma, Qingle, Heng Wang, Bingbing Wu, et al.. (2025). Targeting myeloid cells with platelet-derived extracellular vesicles to overcome resistance of immune checkpoint blockade therapy. Biomaterials. 321. 123336–123336. 3 indexed citations
4.
Ramburrun, Poornima, et al.. (2024). Selenium Nanoparticle Activity against S. mutans Biofilms as a Potential Treatment Alternative for Periodontitis. Pharmaceutics. 16(4). 450–450. 5 indexed citations
6.
Cloete, Karen J., Ž. Šmit, Mahmood Akbari, et al.. (2024). Ionome mapping and amino acid metabolome profiling of Phaseolus vulgaris L. seeds imbibed with computationally informed phytoengineered copper sulphide nanoparticles. SHILAP Revista de lepidopterología. 19(1). 8–8. 5 indexed citations
7.
Dube, Admire, et al.. (2024). Clinically Relevant Metallic Nanoparticles in Tuberculosis Diagnosis and Therapy. Advanced Therapeutics. 8(4). 2 indexed citations
8.
Baker, Priscilla, et al.. (2023). Biosensors as early warning detection systems for waterborne Cryptosporidium. Water Science & Technology. 88(3). 615–630. 1 indexed citations
9.
Myburgh, J. A., Wilna Liebenberg, Clarissa Willers, Admire Dube, & Minja Gerber. (2023). Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems. Pharmaceutics. 15(10). 2413–2413. 7 indexed citations
10.
Gathirwa, Jeremiah, Hamisi M. Malebo, Hulda Swai, et al.. (2023). Chitosan-coated liposomes of Carrisa spinarum extract: synthesis, analysis and anti-pneumococcal potency. Bioinspired Biomimetic and Nanobiomaterials. 1–12. 4 indexed citations
11.
Madiehe, Abram M., Koena Leah Moabelo, Samantha Meyer, et al.. (2022). Catalytic reduction of 4-nitrophenol and methylene blue by biogenic gold nanoparticles synthesized using Carpobrotus edulis fruit (sour fig) extract. Nanomaterials and Nanotechnology. 12. 2779333386–2779333386. 10 indexed citations
12.
Liebenberg, Wilna, et al.. (2022). Comparative study on the topical and transdermal delivery of diclofenac incorporated in nano-emulsions, nano-emulgels, and a colloidal suspension. Drug Delivery and Translational Research. 13(5). 1372–1389. 6 indexed citations
13.
Bideau, Jean Le, Valérie Geoffroy, Boris Halgand, et al.. (2021). Curdlan–Chitosan Electrospun Fibers as Potential Scaffolds for Bone Regeneration. Polymers. 13(4). 526–526. 20 indexed citations
14.
Ramburrun, Poornima, et al.. (2021). Recent Advances in the Development of Antimicrobial and Antifouling Biocompatible Materials for Dental Applications. Materials. 14(12). 3167–3167. 77 indexed citations
15.
Dube, Admire, et al.. (2021). Establishment of the African Medicines Agency: progress, challenges and regulatory readiness. Journal of Pharmaceutical Policy and Practice. 14(1). 29–29. 76 indexed citations
16.
Shemis, Mohamed, Lynne A. Pilcher, Nicole Remaliah Samantha Sibuyi, et al.. (2020). Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin. RSC Advances. 10(34). 19770–19780. 18 indexed citations
17.
Buchtová, Nela, Ashwil Klein, Marique Aucamp, et al.. (2020). Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum. Colloids and Surfaces B Biointerfaces. 188. 110816–110816. 27 indexed citations
18.
Maponga, Charles C., Admire Dube, Justen Manasa, et al.. (2020). Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effort. Journal of Public Health in Africa. 10(2). 1081–1081. 3 indexed citations
19.
Hsu, Nai‐Jen, Jyoti Sharma, Samantha L. Sampson, et al.. (2018). Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines. Pharmaceutical Research. 36(1). 8–8. 20 indexed citations
20.
Chang, Esther H., Joe B. Harford, Michael A. W. Eaton, et al.. (2015). Nanomedicine: Past, present and future – A global perspective. Biochemical and Biophysical Research Communications. 468(3). 511–517. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026